CONTENTS:
- I like to go out and have a good time: An ethnography of a group of young middle class urban Indian women participating in a new drinking culture. Murdeshwar S., Riley S., Mackiewicz A., p. 1-8.
- Aboriginal alcohol policy and practice in Australia: A case study of unintended consequences. d'Abbs P., Burlayn, Jamijin, p. 9-14.
- "Like being put on an ice floe and shoved away": A qualitative study of the impacts of opioid-related policy changes on people who take opioids. Antoniou T., Ala-Leppilampi K., Shearer D., Parsons J.A., Tadrous M., Gomes T., p. 15-22.
- Investigating and validating methods of monitoring foot-traffic in night-time entertainment precincts in Australia. Taylor N., Mayshak R., Curtis A., Coomber K., Chikritzhs T., Miller P., p. 23-29.
- Emergence of Novel Psychoactive Substance injecting associated with rapid rise in the population prevalence of hepatitis C virus. McAuley A., Yeung A., Taylor A., Hutchinson S.J., Goldberg D.J., Munro A., p. 30-37.
- Drug sourcing and motivations among a sample of people involved in the supply of pharmaceutical drugs in Australia. Hulme S., Hughes C.E., Nielsen S., p. 38-47.
- Social network ties to nightlife and healthcare professionals and prescription drug misuse among young adults. Kelly B.C., Vuolo M., p. 48-56.
- Youth perspectives on concurrent smoking and vaping: Implications for tobacco control. Antin T.M.J., Hunt G., Kaner E., Lipperman-Kreda S., p. 57-63.
- The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency. Wallace B., Pagan F., Pauly B., p. 64-72.
- Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1-6 receiving opioid substitution therapy. Grebely J., Dore G.J., Alami N.N., Conway B., Dillon J.F., Gschwantler M., et al., p. 73-79.
- The tripping point: The potential role of psychedelic-assisted therapy in the response to the opioid crisis. Argento E., Tupper K.W., Socias M.E., p. 80-81.
- Evaluation of the fentanyl patch-for-patch program in Ontario, Canada. Tadrous M., Greaves S., Martins D., Nadeem K., Singh S., Mamdani M.M., et al., p. 82-86.
- Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs. Day E., Broder T., Bruneau J., Cruse S., Dickie M., Fish S., et al., p. 87-93.
- Is policy 'liberalization' associated with higher odds of adolescent cannabis use? A re-analysis of data from 38 countries. Stevens A., p. 94-99.